Tesla shares fell in extended trading Wednesday after the electric vehicle maker's fourth-quarter revenue and adjusted profit came in lower than expectations.

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...

Tesla Inc. disappointed investors on Thursday, reporting sales of 495,570 electric vehicles in the fourth quarter and of 1.789 ... Tesla’s stock TSLA fell more than 6% on the news, stretching ...

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

Investing in stocks with high valuations isn't necessarily a bad decision, but it's something to be done deliberately and ...